Practically Speaking: Durvalumab in limited stage small cell lung cancer

To be added to the distribution list, please email: DDeCastro@southlake.ca

In this episode of MedOncNow, Dr. David Dawe discusses consolidation durvalumab in limited stage small cell lung cancer after chemo rads. This is timely given we now have access through a company sponsored access program for consolidation durvalumab. 

Key Opinion Leader: 

David Dawe, MD MSc FRCPC
Medical Oncologist, CancerCare Manitoba
Assistant Professor, University of Manitoba
Affiliate Scientist, CancerCare Manitoba Research Institute

Host:
Shaqil Kassam MD. MSc. FRCPC
skassam@southlake.ca
Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Previous episodes: https://www.blogtalkradio.com/medoncnow

X- @medoncnow